Purchases and Sales Made in Q2 2021 in Chemomab Therapeutics Ltd. (CMMB)
This table provides information about the institutional ownership of Chemomab Therapeutics Ltd. (CMMB) during Q2 2021. The information is specifically focused on institutions that hold shares of Chemomab Therapeutics Ltd..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 16, 2021
Q2 2021
|
Ikarian Capital, LLC
Dallas, TX |
BUY
|
- |
291KNew |
$4.67M - $16M
|
291K
$282K
|
|
Aug 13, 2021
Q2 2021
|
Marshall Wace, LLP
London, X0 |
BUY
|
- |
63.6KNew |
$1.02M - $3.5M
|
63.6K
$61.6K
|
|
Aug 05, 2021
Q2 2021
|
Meitav Dash Investments LTD
|
BUY
|
- |
32.4K+ 389.28% |
$520K - $1.78M
|
40.7K
$39.4K
|
|
Sep 17, 2021
Q2 2021
|
Virtu Financial LLC
New York, NY |
BUY
|
- |
13.2KNew |
$212K - $725K
|
13.2K
$12.8K
|
|
Jul 26, 2021
Q2 2021
|
Spire Wealth Management
|
BUY
|
- |
500New |
$8.04K - $27.5K
|
500
$485
|
|
Aug 13, 2021
Q2 2021
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Aug 16, 2021
Q2 2021
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-76Closed |
$1.22K - $4.18K
|
0
$0
|
|
Jul 29, 2021
Q2 2021
|
Ironwood Financial, LLC
|
SELL
|
- |
-160- 95.81% |
$2.57K - $8.8K
|
7
$6.79
|
|
Aug 13, 2021
Q2 2021
|
Ubs Group Ag
|
SELL
|
- |
-695- 83.33% |
$11.2K - $38.2K
|
139
$135
|
|
Aug 13, 2021
Q2 2021
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-7.02KClosed |
$113K - $386K
|
0
$0
|
|
Aug 16, 2021
Q2 2021
|
Boothbay Fund Management, LLC
New York, NY |
SELL
|
- |
-7.03K- 11.39% |
$113K - $387K
|
54.7K
$53.1K
|
|
Aug 11, 2021
Q2 2021
|
Cvi Holdings, LLC
Wilmington, DE |
SELL
|
- |
-93.8KClosed |
$1.51M - $5.16M
|
0
$0
|
|
Aug 16, 2021
Q2 2021
|
Maven Securities LTD
St Helier, Y9 |
SELL
|
- |
-127KClosed |
$2.03M - $6.96M
|
0
$0
|